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Abstract
Introduction: Increasing numbers of older patients are undergoing emergency laparotomy (EL). They are at increased risk of adverse
outcomes, making the shared decision on whether to operate challenging. This retrospective cohort study aimed to assess the role of
age and life-expectancy predictions on short- and long-term survival in patients undergoing EL.
Methods: All patients who underwent EL at one hospital in the West of Scotland between March 2014 to December 2016 were in-
cluded. Clinical parameters were collected, and patients were followed up to allow reporting of 30-, 60- and 90-day and 1-year mortal-
ity rates. Period life expectancy was used to stratify patients into below life expectancy (bLEP) and at-or-above life expectancy (aLEP)
groups at presentation. Remaining life expectancy was used to calculate the net years of life gained (NYLG).
Results: Some 462 patients underwent EL: 20 per cent in the aLEP group. These patients were older (P< 0.001), had more co-
morbidities (P< 0.001) and were high risk on P-POSSUM scoring (P¼ 0.008). The 30-, 60- and 90-day and 1-year mortality rates were 11,
14, 16 and 23 per cent respectively. Advanced age (P¼ 0.011) and high ASA score (P¼ 0.004) and P-POSSUM score (P< 0.001) were inde-
pendent predictors of death at 1 year on multivariable analysis. The cohort NYLG were 19.2 years. Comparing patients aged less than
70 with those aged 70 years or older, the NYLG were 25.9 versus 5.5 years. Comparing bLEP and aLEP, the NYLG were 22.2 versus
4.4 years. In patients aged 70 years and older, NYLG decreased by more than half in patients with co-morbidities (ASA score 3,4,5) (9.3
versus 4.3 years).
Conclusion: Discussions around long-term outcomes after emergency surgery remain difficult. Although age is an influencing factor,
predicted life expectancy alone does not provide additional value to shared decision making.
Introduction
Increasing numbers of patients with advanced age are undergoing
emergency laparotomy (EL)1. These older adults (70 years of age and
older) make up around half of the cohort in the National Emergency
Laparotomy Audit (NELA) and have a significantly increased risk of
adverse outcomes and postoperative complications2–11. As a conse-
quence, the shared decision regarding whether or not to operate in
this group of patients is often challenging due to the need to balance
the predicted therapeutic benefits of EL against the potential signifi-
cant risks, which include death and a reduced quality of life12. With
the added complexity that application of age alone may underesti-
mate potential outcomes for a healthy older adult, it remains un-
known whether evaluation of patients’ predicted life expectancy
could aid such decisions.
Life expectancy is a measure of the average time someone is
expected to live and, in the UK, is calculated annually by the
National Records of Scotland (NRS) and the Office of National
Statistics (ONS). There are two different types of life
expectancies: cohort and period13,14. Cohort life expectancy is
calculated based on a combination of observed and predicted
mortality rates, taking into account the changes in mortality
rates throughout the lifetime of the cohort. For example, lifestyle
behaviour changes and improved treatments could lead to
improvements in cohort life expectancy, whereas a disease pan-
demic might lead to a reduction. In contrast, period life expec-
tancy (PLE) assumes that the mortality rates stay constant
throughout the remainder of a person’s life. PLE is used by the
ONS and NRS to demonstrate trends in life expectancy and to
produce life tables for a cohort of individuals born and alive
within a specific period of time (example shown in Fig. S1).
In addition to including life expectancy at birth (PLE), life
tables predict the percentage of the population surviving to a par-
ticular year of age and subsequently, the remaining life expec-
tancy (RLE) for people at different ages. For example, at
emergency presentation, a 70-year-old male patient who resides
in an area with a Scottish Index of Multiple Deprivation (SIMD)
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quintile of 1 (high deprivation score) has a PLE of 71.4 years (pre-
dicted life expectancy at birth). Interpretation of the life tables
show that at the age of 70, he is one of 61 465 males (out of
100 000) that have reached this age, giving him a predicted RLE of
11.9 years. As a result, these life tables potentially allow quantifi-
cation of years of life gained for patients considering undergoing
EL. If such patients survive, these life tables may have a role in
aiding shared decision making.
The aim of this study was to assess the role of age and life-ex-
pectancy predictions on short- and long-term survival in all
patients undergoing emergency laparotomy.
Methods
The study has been reported using the STROBE guidelines15. All
patients who underwent EL at one hospital in the West of Scotland
between March 2014 and December 2016 were included. Patients
were identified from a prospectively maintained database where lo-
cal data are submitted centrally to the Scottish Government as part
of their Modernising Patient Pathways Programme16. A standardized
data collection pro forma was used17. A Caldicott Guardian and the
research and development team of NHS Greater Glasgow and Clyde
granted approvals for data usage.
Patient inclusion and exclusion criteria
Consecutive patients over the age of 18 who underwent EL were
included according to the NELA inclusion criteria (Appendix S1)18.
EL patients who had surgery for any condition related to the ap-
pendix or gallbladder, hernia repair with no bowel resection,
trauma and planned return to theatre were excluded according
to the NELA criteria.
Variables collected
The following clinical parameters were collected: age, sex, SIMD
quintile19, ASA score20 and P-POSSUM score. Patients were fol-
lowed up to allow reporting of 30-, 60- and 90-day and 1-year
mortality rates.
For analysis, age was grouped into less than 70 years old
(younger adults) and 70 years and over (older adults); ASA and
SIMD quintiles were grouped into 1, 2 and 3, 4, 5 combined, to aid
with statistical analysis. The use of P-POSSUM for risk prediction
has been inconsistent within the literature, in particular overesti-
mating risk in low-risk patients and the opposite for high-risk
patients21–25. To overcome this limitation, patients were catego-
rized into low- (less than 5 per cent) or high-risk (greater than or
equal to 5 per cent) groups as per guidelines from the Royal
College of Surgeons of England, so as to allow better identifica-
tion of high-risk patients10.
Socioeconomic deprivation has been associated with poorer
postoperative outcomes26. SIMD is a deprivation score allocated
to each of the 6976 data zones (similarly sized areas of approxi-
mately 760 people) in Scotland. Thirty-eight indicators of depri-
vation are grouped into seven domains to generate an SIMD,
which is used to rank each data zone from one (most deprived) to
6976 (least deprived). This is further subcategorized into quintiles
(one to five) and the postcode of individual patients was used to
identify the corresponding SIMD quintile based on the latest in-
dex (SIMD 2016)27.
Period life expectancy and remaining life
expectancy
The PLE and RLE of each patient for a given age, sex and SIMD
quintile were obtained from the 2014–2016 Scottish abridged life
table as published by the NRS14. The authors used the Scottish
life table as it provided age, sex, deprivation status-matched PLE
and remaining years of life.
PLE was used to stratify patients based on their age at EL pre-
sentation into two groups: below life expectancy at presentation
(bLEP) and at or above life expectancy at presentation (aLEP).
Interpretation of the life tables allowed the use of RLE for each
patient to calculate the net years of life gained (NYLG) for each
patient who was alive at 1 year after EL (Table 1)28.
NYLG is an objective measure of the true therapeutic benefit
of EL as it accounts for the years of life lost from the procedure to
arrive at a number for the true years of life gained for each EL
performed.
For further analysis of NYLG, patients were categorized into
subgroups based on: age less than 70 years versus greater than or
equal to 70 years; age at presentation for EL in relation to their
PLE; and the presence or absence of significant co-morbidities
(ASA 1, 2 versus ASA 3, 4, 5).
Statistical analysis
Descriptive analysis of the cohort was reported. Pearson v2 test
was used to assess the relationship between categorical variables
and mortality rates. Univariable Cox proportional hazards regres-
sion analysis was performed on patient risk factors for death.
Variables with P< 0.100 were subsequently included in multivari-
able analysis to identify independent predictors of death at 30, 60
and 90 days and 1 year. P< 0.050 was considered statistically sig-
nificant in the multivariable analysis. Statistical analysis was
performed using IBM SPSSTM, version 23 (IBM Corp, Armonk, New
York, USA).
Table 1 Calculation of net years of life gained from emergency laparotomy
EL EL patients alive at 1 year
Number a ¼ Total number of ELNumber of EL patients alive at 1 year 1
Average potential years of life gained – b
Average potential years of life lost c –
1-year mortality rate of EL d –
Years of life gained – e ¼ 1  b
Years of life lost f ¼ a  c  d –
Net years of life gained e–f
a, the number of emergency laparotomy (EL) procedures performed for each patient alive at 1 year. b, average potential years of life gained (PYLG); PYLG was
defined as the number of years of life gained if a patient was alive at 1 year after EL. c, average potential years of life lost (PYLL); PYLL was defined as the number of
years of life lost if a patient was dead at 1 year after EL. d, 1-year mortality rate of EL (in specific cohorts). e, years of life gained. f, years of life lost (after accounting
for number of EL performed for each patient alive at 1-year and mortality rate of EL). Net years of life gained ¼ years of life gained (e) – years of life lost (f).
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Results
Characteristics of emergency laparotomy patients
A total of 462 patients underwent EL during the study period
(Table 2). The majority of patients were female (242 patients, 52.4
per cent), less than 70 years old (285 patients, 61.7 per cent) with
50.4 per cent coming from the most deprived areas (SIMD 1 or 2;
233 patients). More than half of the patients had co-morbidities
(290 patients, 62.8 per cent) and were considered high risk (261
patients, 56.5 per cent). The 30-, 60- and 90-day and 1-year mor-
tality rates of patients who had EL were comparable to those of
NELA data, at 11.3, 14.1, 16.0 and 22.7 per cent respectively
(Table 3).
Period life expectancy at presentation
Some 80 per cent of patients presented at an age below their PLE
(369 patients; bLEP group) (Table 4). Comparison of the two groups
found that patients in the aLEP group were older (100 per cent
70 years old or over, P< 0.001), more likely to present with co-
morbidities (84.9 versus 57.2 per cent, P< 0.001) and more likely to
be categorized as high risk (68.8 versus 53.5 per cent, P¼ 0.008).
Mortality rates
Patients with advanced age (70 years old and above) and those
that presented at or above their PLE (aLEP) consistently reported
greater short- and long-term mortality rates. The presence of co-
morbidities in patients aged 70 years old and above was signifi-
cantly associated with greater 90-day and 1-year mortality rates,
but not greater 30- or 60-day mortality rates (Table 3).
High ASA and P-POSSUM scores were independently predictive
of death at 30, 60 and 90 days and 1 year on multivariable analy-
sis (Table S1). Advanced age was an independent predictor of
death at 1 year (hazard ratio 1.88, 95 per cent c.i. 1.16 to 3.05,
P¼ 0.011), after adjusting for ASA (P¼ 0.004) and P-POSSUM score
(P< 0.001).
Potential years of life gained and lost and net
years of life gained
The calculation of the mean NYLG for each patient’s death
avoided (alive at 1 year) through EL is shown in Table S2. For each
patient alive at 1 year after EL (357 patients), an average of 1.29
cases of EL (462 patients) was performed. EL was associated with
a 1-year mortality rate of 22.7 per cent and an average potential
years of life lost (PYLL) of 17.1 years for each death at 12-months’
follow-up in this cohort. This amounted to 5.0 years of life lost,
which was then subtracted from an average potential years of
life gained (PYLG) of 24.3 years, resulting in a net gain of
19.2 years of life for each patient alive at 1 year after EL.
Potential years of life gained and lost and net
years of life gained stratified by age at
presentation
The difference between the patients aged under 70 years and
patients 70 years old and over is shown in Table S3. Patients under
70 had an average PYLG of 30.6 years, three times that of older
patients. This resulted in a much greater NYLG in younger
patients when compared with that of patients aged 70 and above
(25.9 years versus 5.5 years). The NYLG reduced further in patients
aged 80 years old and over to 3.7 years.
Potential years of life gained and lost and net
years of life gained stratified by period life
expectancy at presentation
The bLEP patients had a much greater PYLG and PYLL (27.4 and
21.3 years respectively) compared with aLEP patients (8.8 and
7.9 years respectively), hence the greater NYLG in bLEP patients
(22.2 versus 4.4 years) (Table S4).
Potential years of life gained and lost and net
years of life gained stratified by the presence of
co-morbidities
The effect of co-morbidities on the NYLG was compared in older
patients (over 70 and over 80 years old) (Table S5). In patients aged
70 and above, the PYLG was similar regardless of the presence of
co-morbidities (12.1 versus 10.9 years). However, the NYLG de-
creased by more than half in patients with co-morbidities (4.3
Table 3 Mortality rates of emergency laparotomy patients
Deaths
30-day 60-day 90-day 1-year
Overall (n 5 462) 52 (11.3) 65 (14.1) 74 (16.0) 105 (22.7)
versus NELA (9.5) – (12.9) (23.2)
Age (years)
<70 (n¼ 285) 24 (8.4) 29 (10.2) 34 (11.9) 44 (15.4)
70 (n¼ 177) 28 (15.8) 36 (20.3) 40 (22.6) 61 (34.5)
P 0.014 0.002 0.002 <0.001
Life expectancy at EL
Below (n¼ 369) 36 (9.8) 44 (11.9) 51 (13.8) 72 (19.5)
At or above (n¼ 93) 16 (17.2) 21 (22.6) 23 (24.7) 33 (35.5)
P 0.042 0.008 0.010 0.001
Presence of co-morbidities in patients aged 70 years old and above
ASA <3 (n¼ 34) 2 (5.9) 3 (8.8) 3 (8.8) 6 (17.6)
ASA 3 (n¼ 143) 26 (18.2) 33 (23.1) 37 (25.9) 55 (38.5)
P 0.077 0.063 0.033 0.022
Values in parentheses are percentages.
















Deprived (1, 2) 233 (50.4)








No co-morbidities (1, 2) 172 (37.2)
With co-morbidities (3, 4, 5) 290 (62.8)
P-POSSUM
Low-risk (<5%) 200 (43.3)
High-risk (5%) 261 (56.5)
Values in parentheses are percentages.
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versus 9.3 years). A similar result was observed in patients aged
80 and above, with a NYLG of only 3.1 years in patients with co-
morbidities.
Discussion
Acknowledging that age is an influencing factor, this study ex-
plored the potential role of using age and PLE to predict long-
term mortality rates in patients undergoing EL so that it could be
used as an adjunct for decision making for EL. Twenty per cent of
patients presented above their PLE with nearly 65 per cent being
alive 1 year later. Undergoing EL at any age was associated with
net years of life gained, however this gain reduced with increas-
ing age. With physiological factors found to be independent of
age, this work shows that whilst age and PLE can guide short-
and long-term mortality outcomes, they are not reliable nor are
they absolute discriminators, limiting their utility in aiding deci-
sion making in the emergency setting.
The perioperative team’s decision to operate and subsequent
levels of care can be based on numerous factors, including the
patient’s fitness based on scoring systems (for example, NELA
risk score), frailty29, age, the presence of co-morbidities and
objective markers of physical health30. It is rarely based on one
solitary factor and can be especially challenging in the time-
pressured emergency surgery setting. In this study, co-
morbidities and being classified as high risk were shown again to
be independent predictors of increased mortality rate31,32. The
negative influence of increasing age was also confirmed with
patients over the age of 70 doubling their short- and long-term
mortality rates compared with those of adults under 70 years old.
It is likely that those poorer older-adult outcomes were not a re-
sult of age per se but reflect a greater prevalence of co-morbidity
in older age groups: a 1-year mortality rate of 34.5 per cent in-
creased to 38.8 per cent if two or more co-morbidities were pre-
sent. A recent study characterized an alternative group of
patients who fulfil criteria for EL but who do not proceed to sur-
gery, the ‘NoLap’ cohort33. These patients make up one-third of
admissions with an acute surgical abdomen and up to 30 per
cent of these patients are alive 30 days after admission. Surgery
is deemed futile in these patients, either due to poor fitness or ad-
vanced malignancies. This alternative should be taken into
consideration when deciding whether to operate or not, as elderly
patients with limited physiological reserve will have a shorter life
expectancy and potentially a poorer quality of life with postoper-
ative complications.
In this study the influence of age was explored further by ap-
plying life expectancy predictions accompanied by estimates of
years of life gained and lost. The results found that PLE using
data from national audits cannot be applied in emergency surgi-
cal decision making as one fifth of patients present above their
PLE. In addition, a significant number survive despite having
higher ASA scores and greater co-morbidity than those that pre-
sent before their PLE. The potential role of NYLG was then ex-
plored using life tables, finding that all age groups had predicted
net gains in years of life. Clearly this limits the clinical applicabil-
ity of life tables in the emergency surgical setting.
Findings from this study support the discussion of the influ-
ence of age and life expectancy in the general context of an in-
creased risk of mortality with older patients. However, greater
consideration should be given to the physiological and physical
fitness of the individual older adult when deciding on both treat-
ment options and possible long-term outcomes. Indeed, with
high-risk patients and those with with co-morbidities being at
greatest risk, alternative prognosticators to age, such as frailty,
should be integrated in the EL setting29.
Gained net years after EL seems like a positive outcome, how-
ever, it is not clear what those predicted gains mean for the day-
to-day living of individual patients. The possibility of recurrent
readmissions or clinic attendances or increasing care/nursing
home to overcome reducing independence are not considered in
this study, but have been reported as important outcome meas-
ures expressed by patients that have undergone EL12. With NELA
initially focusing on reducing mortality rates, consideration to
long-term patient needs, including quality of life, is an unex-
plored and clearly needed, research area.
Although this study is limited by being a single-centre study
with a relatively small cohort compared with national audits, the
patients have similar baseline characteristics and mortality rates
to NELA, hence generalizability of the results. It is acknowledged
that alternative methods for the calculation of NYLG are avail-
able and may offer improved insights; this is, however, an evolv-
ing area that is still poorly understood.
Table 4 Basic demographics of emergency laparotomy patients subdivided by their period life expectancy (using age at presentation)
Characteristic Patients P
Below life expectancy At or above life expectancy
(n¼369) (n¼93)
Gender
Female 192 (52.0) 50 (53.8)
Male 177 (48.0) 43 (46.2) 0.765
Age (years)
<70 285 (77.2) 0 (0.0)
70 84 (22.8) 93 (100.0) <0.001
SIMD category
Deprived (1, 2) 180 (48.8) 53 (57.0)
Non-deprived (3, 4, 5) 189 (51.2) 40 (43.0) 0.157
ASA category
No co-morbidities (1, 2) 158 (42.8) 14 (15.1)
With co-morbidities (3, 4, 5) 211 (57.2) 79 (84.9) <0.001
P-POSSUM
Low risk (<5%) 171 (46.5) 29 (31.2)
High-risk (5%) 197 (53.5) 64 (68.8) 0.008
Values in parentheses are percentages.
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